Day: July 6, 2020

HOUSTON, July 06, 2020 (GLOBE NEWSWIRE) — Contango Oil & Gas Company (NYSE American: MCF) (“Contango” or the “Company”) announced today that Farley Dakan has been promoted to the position of President of the Company. Additionally, the Company has appointed Chad Roller as Senior Vice President – Chief Operating Officer and Chad McLawhorn as Senior Vice President – General Counsel and Corporate Secretary of the Company. Wilkie Colyer, previously the Company’s President & Chief Executive Officer, will remain the Company’s Chief Executive Officer. Messrs. Dakan, Roller, and McLawhorn will report to Mr. Colyer.Chad Roller, PhD, most recently served as President and Chief Operating Officer of the general partner for Mid-Con Energy Partners, LP. Previously, he served as Vice President of Development and Petroleum Engineer at...

LONGUEUIL, Quebec, July 06, 2020 (GLOBE NEWSWIRE) — Highland Copper Company Inc. (TSXV: HI, OTCQB: HDRSF) (the “Company”) announced today that the deadline to complete the acquisition of the White Pine North Project from Copper Range Company (“CRC”), a wholly owned subsidiary of First Quantum Minerals Ltd., was extended to December 31, 2020. The final closing of the acquisition is subject to a number of conditions, including, without limitation, a release of CRC from certain environmental obligations associated with the remediation and closure plan of the historical White Pine mine site and replacing the related environmental bond.About HighlandHighland Copper Company Inc. is a Canadian company focused on exploring and developing copper projects in the Upper Peninsula of Michigan, U.S.A. Its Copperwood Project is a development stage...

NEW YORK, 06 juill. 2020 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS), une société biopharmaceutique de stade clinique spécialisée dans le développement d’immunothérapies fondées sur des cellules CAR-T allogéniques ingénierées (UCART), annonce que l’essai clinique MELANI-01 a été suspendu par la Food and Drug Administration (FDA) aux États-Unis. Cette suspension, qui concerne un des trois produits candidats de Cellectis actuellement en étude clinique, intervient suite à la soumission d’un rapport de sécurité concernant un patient atteint de myélome multiple récidivant et réfractaire inclus dans l’étude clinique MELANI-01 au palier de la dose 2. Avant son inclusion dans l’étude, ce patient avait reçu de nombreux traitements sans succès y compris des cellules CAR-T autologues, et a été...

LONDON, UK, July 06, 2020 (GLOBE NEWSWIRE) — Leo Holdings Corp. (“Leo”) (NYSE: LHC), today announced that, due to the public health and safety concerns related to the coronavirus (COVID-19) pandemic and recommendations and orders from federal and New York authorities, the extraordinary general meeting of Leo’s shareholders, which will be held on Tuesday, July 14, 2020 at 9:00 a.m., New York City Time (the “General Meeting”) will be held remotely by teleconference. The purpose of the General Meeting is to vote on certain proposals relating to the previously announced Business Combination Agreement, dated as of April 23, 2020 (the “Business Combination Agreement”), by and among Leo, Digital Media Solutions LLC (“DMS”) and the other parties thereto.The General Meeting will be accessible by dialing (833) 780-7941 (toll free – North...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FORDISSEMINATION IN THE UNITED STATESTORONTO, July 06, 2020 (GLOBE NEWSWIRE) — Olivut Resources Ltd. (“Olivut” or the “Company”) (TSXV:OLV)  is pleased to announce that it has exercised its option to earn 50% of the Seahorse Project, located in the Northwest Territories, Canada in accordance with the terms of the Option Agreement signed with Talmora Diamond Inc. (“Talmora”) on July 6, 2018.  Olivut and Talmora will be joint (50/50) owners of the assets.   All earn-in requirements have been completed: on December 9, 2019 Olivut provided notice to Talmora that it had incurred the minimum work cost requirement of $1,200,000 ($1,295,000 spent to October 31, 2019) and a cash payment of $200,000 was made to Talmora in July, 2018.  Talmora retains a 1% net smelter return royalty...

HOUSTON, July 06, 2020 (GLOBE NEWSWIRE) — SEACOR Marine Holdings Inc. (NYSE: SMHI) (the “Company” or “SEACOR Marine”), a leading provider of marine and support transportation services to offshore oil and natural gas and wind farm facilities worldwide, today announced that on June 30, 2020, a wholly-owned subsidiary of the Company completed the acquisition of the remaining 50% of equity interests in SEACOSCO Offshore LLC (“SEACOSCO”) that it did not already own from affiliates of COSCO SHIPPING GROUP (“COSCO”). SEACOR Marine will consolidate the operating results of SEACOSCO as a 100% owned subsidiary from and after the closing date.  The acquisition further modernizes SEACOR Marine’s fleet through consolidating the Company’s ownership of eight Rolls-Royce designed platform supply vessels (“PSVs”).  Six of the PSVs are of UT 771WP...

NEW YORK, July 06, 2020 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS), a biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), today announced that the MELANI-01 trial has been placed on clinical hold by the U.S. Food and Drug Administration (FDA).  This clinical hold which impacts one of the three Cellectis product candidates currently in clinical studies, was initiated following the submission of a safety report regarding one patient enrolled in the MELANI-01 study at dose level two (DL2), with relapsed and refractory multiple myeloma. This patient, who had been treated unsuccessfully, prior to enrollment with numerous lines of prior therapy, including autologous CAR T-cells, experienced a fatal treatment-emergent adverse event of cardiac...